Jiri Fronek1,2,3, Jakub Kristek1,2, Jaroslav Chlupac1,2, Libor Janousek1,3, Michael Olausson4. 1. Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21 Prague, Czech Republic. 2. Department of Anatomy, Second Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic. 3. First Faculty of Medicine, Charles University, Katerinska 1660/32, 121 08 Prague, Czech Republic. 4. Department of Transplantation Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Bla Straket 5, 413 45 Gothenburg, Sweden.
Abstract
INTRODUCTION: Uterus transplantation (UTx) is a rapidly evolving treatment of uterine-factor infertility. We report the results of the first 10 UTx procedures performed at our institution. METHODS: The program started in April 2016 as a two-arm study comparing the efficacy of UTx from live donors (LD) and deceased donors (DD). RESULTS: Between April 2016 and April 2018, we performed five DD UTx and five LD UTx. Two grafts had to be removed early due to thrombosis. One graft was removed due to chronic rejection and previous herpes simplex infection at month 7. Graft survival is 70% at one year. Recipient survival is 100% at two years. Live donor survival is 100% at three years. Three live-births have been achieved, two from a LD and one from a graft from a nulliparous DD. Vaginal anastomotic stenosis occurred in 63% (5/8) of grafts. Self-expanding stents have shown preliminary suitability for the treatment of vaginal stenosis. Three recipients developed severe acute rejection. CONCLUSION: The interim results of our study demonstrate mid-term viability in 70% of grafts. The LD UTx produced two live births and the DD UTx produced one live birth. Nulliparous donors should be considered for donation.
INTRODUCTION: Uterus transplantation (UTx) is a rapidly evolving treatment of uterine-factor infertility. We report the results of the first 10 UTx procedures performed at our institution. METHODS: The program started in April 2016 as a two-arm study comparing the efficacy of UTx from live donors (LD) and deceased donors (DD). RESULTS: Between April 2016 and April 2018, we performed five DD UTx and five LD UTx. Two grafts had to be removed early due to thrombosis. One graft was removed due to chronic rejection and previous herpes simplex infection at month 7. Graft survival is 70% at one year. Recipient survival is 100% at two years. Live donor survival is 100% at three years. Three live-births have been achieved, two from a LD and one from a graft from a nulliparous DD. Vaginal anastomotic stenosis occurred in 63% (5/8) of grafts. Self-expanding stents have shown preliminary suitability for the treatment of vaginal stenosis. Three recipients developed severe acute rejection. CONCLUSION: The interim results of our study demonstrate mid-term viability in 70% of grafts. The LD UTx produced two live births and the DD UTx produced one live birth. Nulliparous donors should be considered for donation.
Entities:
Keywords:
absolute uterine-factor infertility; deceased donors; living donors; uterus transplantation
Authors: Liza Johannesson; Giuliano Testa; J Michael Putman; Gregory J McKenna; E Colin Koon; Jackie R York; Johanna Bayer; Lilly Zhang; Zachary S Rubeo; Robert T Gunby; Anthony R Gregg Journal: Obstet Gynecol Date: 2021-02-01 Impact factor: 7.661
Authors: G Testa; T Anthony; G J McKenna; E C Koon; K Wallis; G B Klintmalm; J C Reese; L Johannesson Journal: Am J Transplant Date: 2017-09-23 Impact factor: 8.086
Authors: Florin-Andrei Taran; Dorit Schöller; Katharina Rall; Silvio Nadalin; Alfred Königsrainer; Melanie Henes; Hans Bösmüller; Falko Fend; Konstantin Nikolaou; Mike Notohamiprodjo; Christian Grasshoff; Eckhard Heim; Stephan Zipfel; Norbert Schäffeler; Tamam Bakchoul; Nils Heyne; Martina Guthoff; Bernhard Krämer; Christl Reisenauer; Markus Hoopmann; Karl-Oliver Kagan; Mats Brännström; Diethelm Wallwiener; Sara Y Brucker Journal: Fertil Steril Date: 2019-01 Impact factor: 7.329
Authors: Jiri Fronek; Libor Janousek; Jakub Kristek; Jaroslav Chlupac; Marek Pluta; Robert Novotny; Jana Maluskova; Michael Olausson Journal: Transplantation Date: 2021-05-01 Impact factor: 4.939
Authors: Jakub Kristek; Michal Kudla; Jaroslav Chlupac; Robert Novotny; Tomas Mirejovsky; Libor Janousek; Jiri Fronek Journal: World J Clin Cases Date: 2019-12-26 Impact factor: 1.337
Authors: Mats Brännström; Hans Bokström; Pernilla Dahm-Kähler; Cesar Diaz-Garcia; Jana Ekberg; Anders Enskog; Henrik Hagberg; Liza Johannesson; Niclas Kvarnström; Johan Mölne; Michael Olausson; Jan I Olofsson; Kenny Rodriguez-Wallberg Journal: Fertil Steril Date: 2016-04-25 Impact factor: 7.329
Authors: Giuliano Testa; Greg J McKenna; Johanna Bayer; Anji Wall; Hoylan Fernandez; Eric Martinez; Amar Gupta; Richard Ruiz; Nicholas Onaca; Robert T Gunby; Anthony R Gregg; Michael Olausson; E Colin Koon; Liza Johannesson Journal: Ann Surg Date: 2020-09-01 Impact factor: 12.969
Authors: Emily H Frisch; Tommaso Falcone; Rebecca L Flyckt; Andreas G Tzakis; Eric Kodish; Elliott G Richards Journal: J Clin Med Date: 2022-08-03 Impact factor: 4.964